Accessibility Menu
111 Stock Quote

111 (NASDAQ: YI)

$4.53
(0.0%)
+0.00
Price as of October 23, 2025, 3:19 p.m. ET

KEY DATA POINTS

Current Price
$4.53
Daily Change
(0.0%) +$0.00
Day's Range
$4.48 - $4.58
Previous Close
$4.53
Open
$4.48
Beta
1.11
Volume
4,356
Average Volume
18,213
Market Cap
22.8M
Market Cap / Employee
$4.53M
52wk Range
$4.15 - $11.35
Revenue
-
Gross Margin
0.06%
Dividend Yield
N/A
EPS
-$1.19
CAPs Rating
-
Industry
Food and Staples Retailing

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

111 Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
YI-45.45%-93.53%-42.16%-97%
S&P+14.5%+93.32%+14.09%+132%

111 Company Info

111, Inc. engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. It operates through the B2C and B2B segments. The B2C segment engages in the sale of pharmaceutical and other health and wellness products directly to consumers through 1 Drugstore and its offline pharmacies. The B2B segment includes the sale of pharmaceutical products to pharmacy customers through 1 Drug Mall. The company was founded by Gang Yu and Jun Ling Liu in May 2013 and is headquartered in Shanghai, China.

News & Analysis

Financial Health

General

Q2 2025YOY Change
Revenue$443.21M-6.3%
Gross Profit$25.63M-10.6%
Gross Margin5.78%-0.3%
Market Cap$36.02M-31.7%
Market Cap / Employee$0.03M0.0%
Employees1.2K-18.6%
Net Income-$2.76M-49.5%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q2 2025YOY Change
Net Cash$71.61M0.9%
Accounts Receivable$47.88M-28.1%
Inventory178.4-5.2%

Liabilities

Q2 2025YOY Change
Long Term Debt$5.99M-22.5%
Short Term Debt$23.72M-9.0%

Ratios

Q2 2025YOY Change
Return On Assets-2.82%8.6%
Return On Invested Capital1741.82%14.3%

Cash Flow

CurrentYOY Change
Operating Free Cash Flow-$8.40M-165.3%

Valuation

MetricQ3 2024Q4 2024Q1 2025Q2 2025YoY Change
Price to Book-0.72-0.61-0.77-0.40-64.25%
Price to Sales0.030.030.040.03-29.62%
Price to Tangible Book Value-4.42-3.44-0.45-0.40-93.82%
Total Debt$33.14M$39.76M$26.92M$29.72M-12.07%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.